Will Morton[email protected]MRICardiac MRI variables boost heart failure predictionSixteen key cardiac MRI variables improved risk prediction.June 23, 2026Molecular ImagingNew PET tracer shows promise for guiding pancreatic cancer therapyThe radiotracer is designed to identify pancreatic tumors eligible for paired therapy with cancer-killing actinium-225 (Ac-225) NMT25.June 19, 2026Digital X-RayPrunes not likely to improve bone health in menThe findings are contrary to similar studies in women.June 16, 2026Nuclear MedicineNew immuno-PET tracer shows promise in prostate cancerCompared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.June 15, 2026Molecular ImagingPSMA-PET/CT halves biopsy rate in prostate cancer patientsA majority of men with equivocal findings on MRI are found on biopsy to have either no cancer or clinically insignificant disease.June 11, 2026Molecular ImagingEarly FAPI-PET scans match 60-minute scans for lung cancer stagingBy convention, most molecular imaging tracers such as F-18 FDG are injected one hour prior to PET scans to allow time for uptake of the tracer by tumors.June 10, 2026Digital X-RayX-ray score linked to hip fracture risk in the elderlyAbdominal aortic calcification (AAC) scores of 5 or higher were significantly associated with hip fractures.June 8, 2026Nuclear MedicineSNMMI ShowCast RoundupScience was the star in Los Angeles at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.June 5, 2026HomeSNMMI: PET reveals new brain activity in multiple sclerosisUnderstanding how and where certain brain connections are lost can help explain the symptoms patients experience.June 2, 2026SNMMI 2026SNMMI: PET tracer that detects deep vein thrombosis wins Image of the YearF-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.June 1, 2026Previous PagePage 2 of 55Next PageTop StoriesEconomics2027 MPFS proposed rule would lift radiology reimbursementIf finalized, the proposed rule is expected to hike reimbursement by 2% for radiology, 2% for nuclear medicine, 3% for interventional radiology, and 3% for radiation oncology.MRIMRI could replace DRE for prostate cancer stagingMRIPetition asks FDA to implement new OEM rule for MRI safetyWomens ImagingIncorrect AI suggestions influence reader performance on mammographyMRIPodcast: MRI tragedy, key aspects of the Colombini family's lawsuit
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
